Gary Piazza
Company: Auburn University
Job title: Chief Scientist, ADT Pharmaceutical LLC & Director, Cancer Research Center
Seminars:
Introducing ADT-007: A Novel PAN-RAS Inhibitor with a Unique Mechanism of Action to Treat Pancreatic Cancer 2:00 pm
Utilizing ultra-high potency and selectivity for killing cancer cells with activated RAS that acts independent of the mutation or isozyme Achieving low potential for intrinsic or acquired resistance and off-target effects to effect a robust response Showcasing antitumor activity in mouse tumor models with target engagement at well tolerated dosages Developing an orally bioavailable prodrug…Read more
day: Day One Track A PM